PDA Midwest August 2018 Dinner Meeting

(Indianapolis, Indiana, August 2018) Performance Validation will be attending and exhibiting at the PDA Midwest August 2018 Dinner Meeting.  At this meeting there will be a networking opportunity and Jay M. Ehrlich, MD, Vice President / Global Patient Safety, Baxter Healthcare Corporation will be presenting on patient safety, pharmacovigilance, medical device vigilance and impact of these activities on other functional areas.… more


New Aseptic Filling Line – Critical Airflow Visualization (Smoke Studies)

The Challenge:

A large Fortune 500 company required  Critical Airflow Visualization testing (Smoke Studies)  on a new aseptic filling line with active RABS barrier configuration.  Additionally, modifications to two existing aseptic filling lines were completed in conjunction with the new filling line.  more


Essentials of Leadership

For Immediate Release (Indianapolis, In, July 20, 2018), Performance Validation is excited to announce the release of Essentials of Leadership: A Systematic Approach to Effective Leadership by Performance Validation’s Director Bruce E. Beck.

Bruce joined Performance Validation as a Board Advisor in 2015, and was elected to the Board in 2018 as the company transitioned to 100% employee ownership.  … more


Out of Specification Results

What happens when a firm obtains out of specification results?

21 CFR 211.192 states:

All drug product production and control records, including those for packaging and labeling, shall be reviewed and approved by the quality control unit to determine compliance with all established, approved written procedures before a batch is released or distributed.… more


Lack of Sterility Assurance – Ranier’s Pharmacy

On July 10, 2018 FDA issued a health care alert for products compounded by Ranier’s Pharmacy do to a lack of sterility assurance. Rainer’s inspection history includes:

  • A 6-page form 483 issued April 22, 2016
  • A warning letter issue March 28, 2017 (for the inspection April 18-22, 2016)
  • A 5-page form 483 issued May 22, 2018 (following an inspection from May 14-22, 2018)

In the warning letter, the FDA recommended:

FDA strongly recommends that your management first undertake a comprehensive assessment of operations, including facility design, procedures, personnel, processes, materials, and systems for the production of human and animal drugs. more


Pharma Admin Office Building Commissioning

Overview

A Greenfield construction project of a new administrative office for an Indiana Pharmaceutical Manufacturer required building commissioning of all utility systems, including HVAC, chilled water, plant steam, heating hot water, compressed air, electrical/lighting, and sanitary and storm sewer systems.

The Solution
The pharmaceutical Manufacturer retained Performance Validation (PV) to perform the building commissioning.… more


Neil Enlow Receives Commissioning Professional Certification

For Immediate Release (Indianapolis, Indiana June 28, 2018). Neil EnlowPerformance Validation (PV) is pleased to recognize Mr. Neil Enlow’s certification as a Certified Commissioning Professional (CCP) by the Building Commissioning Certification Board for demonstrating a high level of competence and experience for the building commissioning process by successfully completing an examination, documenting professional and education achievements and fulfilling prescribed standards of performance and conduct required for CCP.… more


Qualification of Continuous Manufacturing Suite

Continuous Manufacturing Process Train Qualification

The Challenge

A Pharmaceutical Manufacturer in Indiana requested help from Performance Validation (PV) with the commissioning and qualification of a continuous manufacturing process train. The process train was the first commercial continuous manufacturing suite for the company.… more


Critical Airflow – Manufacturing Area Upgrade

The Challenge:

A large Fortune 500 company required  Critical Airflow Visualization testing (Smoke Studies)  after an upgrade to a high-volume filling line with new RABS barriers.  Additionally, there were multiple changes to the layout of the line and room were completed in conjunction with the upgrade.more


Point-of-Care

One of the more interesting and novel cancer therapies is the genetic engineering of the patients T-cells, where the cells are modified to target a specific protein expression on the cancer cell. However, this is a paradigm shift in manufacturing moving from a centralized manufacturing (what we see today at large pharmaceutical companies, or 503B Outsourcing Facilities) to a patient point-of-care or decentralized manufacturing model.  … more